Insider · CIK 0001632326
Reza Zadno
Files at MOBI (Mobia Medical, Inc.), PRCT (PROCEPT BioRobotics Corp). First filing Oct 31, 2024, latest Dec 6, 2024.
In brief
Reza Zadno files SEC Form 4 as CEO, president and director at PRCT (PROCEPT BioRobotics Corp), and also at MOBI (Mobia Medical, Inc.). Since Oct 31, 2024, Reza Zadno has reported 0 open-market buys worth $0 and 5 open-market sells worth $36M, the latest filed on Dec 6, 2024.
A track record needs three past buys with six months of prices behind them; Reza Zadno has 0, so none is measured yet.
The newest scored trade: sold $2.6M of PRCT on Dec 4, 2024, filed Dec 6, 2024, scored 43 (moderate), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PRCT: PROCEPT BioRobotics Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | PROCEPT BioRobotics Corp | $2.6M 26,423 shares | -15% | - | |
| 43Moderate | PROCEPT BioRobotics Corp | $2.6M 26,420 shares | -13% | - | |
| 43Moderate | PROCEPT BioRobotics Corp | $2.4M 26,420 shares | -11% | - | |
| 43Moderate | PROCEPT BioRobotics Corp | $2.5M 26,420 shares | -10% | - | |
| 63Notable | PROCEPT BioRobotics Corp | $26M 288,461 shares | -53% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 18, 2025 | PRCT PROCEPT BioRobotics Corp | 5,475 0.01% of outstanding | $312k | Mar 18, 2025 | $976k |
| Mar 6, 2025 | PRCT PROCEPT BioRobotics Corp | 15,916 0.03% of outstanding | $976k | Mar 6, 2025 | none |
| Dec 4, 2024 | PRCT PROCEPT BIOROBOTICS CORP | 26,423 0.05% of outstanding | $2.5M | Dec 4, 2024 | $7.5M |
| Nov 27, 2024 | PRCT PROCEPT BIOROBOTICS CORP | 26,420 0.05% of outstanding | $2.6M | Nov 27, 2024 | $4.9M |
| Nov 20, 2024 | PRCT PROCEPT BIOROBOTICS CORP | 26,420 0.05% of outstanding | $2.5M | Nov 20, 2024 | $2.5M |
| Nov 13, 2024 | PRCT PROCEPT BIOROBOTICS CORP | 26,420 0.05% of outstanding | $2.5M | Nov 13, 2024 | none |
Transactions
Every row this insider has filed, 22 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | MOBI Mobia Medical, Inc. | AGrant or award Stock Optionderivative | +19,150 | $0.00 | $0 | 19,150 | Jul 16, 2026 |
| Jul 14, 2026 | MOBI Mobia Medical, Inc. | AGrant or award Stock Optionderivative | +16,260 | $0.00 | $0 | 16,260 | Jul 16, 2026 |
| May 9, 2025 | PRCT PROCEPT BioRobotics Corp | MOption exercise Common Stock | +13,759 | $7.27 | $100k | 186,829 | May 13, 2025 |
| May 9, 2025 | PRCT PROCEPT BioRobotics Corp | MOption exercise Stock Option (Right to Buy)derivative | -13,759 | $0.00 | $0 | 158,871 | May 13, 2025 |
| Dec 4, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -5,300 | $96.15 | $510k | 173,885 | Dec 6, 2024 |
| Dec 4, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -13,762 | $97.01 | $1.3M | 160,123 | Dec 6, 2024 |
| Dec 4, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -5,126 | $98.09 | $503k | 154,997 | Dec 6, 2024 |
| Dec 4, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -2,235 | $99.04 | $221k | 152,762 | Dec 6, 2024 |
| Nov 27, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -18,144 | $97.25 | $1.8M | 187,461 | Dec 2, 2024 |
| Nov 27, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -1,684 | $98.00 | $165k | 185,777 | Dec 2, 2024 |
| Nov 27, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -5,189 | $99.24 | $515k | 180,588 | Dec 2, 2024 |
| Nov 27, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -1,403 | $99.96 | $140k | 179,185 | Dec 2, 2024 |
| Nov 20, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -10,111 | $92.12 | $931k | 221,914 | Nov 22, 2024 |
| Nov 20, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -15,809 | $92.82 | $1.5M | 206,105 | Nov 22, 2024 |
| Nov 20, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -500 | $93.88 | $47k | 205,605 | Nov 22, 2024 |
| Nov 13, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -10,509 | $92.74 | $975k | 247,936 | Nov 15, 2024 |
| Nov 13, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -2,000 | $93.64 | $187k | 245,936 | Nov 15, 2024 |
| Nov 13, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -9,401 | $94.95 | $893k | 236,535 | Nov 15, 2024 |
| Nov 13, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock10b5-1 | -4,510 | $95.58 | $431k | 232,025 | Nov 15, 2024 |
| Oct 30, 2024 | PRCT PROCEPT BioRobotics Corp | MOption exercise Common Stock | +288,461 | $4.37 | $1.3M | 546,906 | Oct 31, 2024 |
| Oct 30, 2024 | PRCT PROCEPT BioRobotics Corp | SOpen-market sale Common Stock | -288,461 | $91.00 | $26M | 258,445 | Oct 31, 2024 |
| Oct 30, 2024 | PRCT PROCEPT BioRobotics Corp | MOption exercise Stock Option (Right to Buy)derivative | -288,461 | $0.00 | $0 | 961,148 | Oct 31, 2024 |
Questions about Reza Zadno
Answered from the filings on this page, as of the latest one.
Is Reza Zadno buying or selling?
Not in the last 12 months. Reza Zadno's latest open-market trade on SEC Form 4 was sold $2.6M of PRCT on Dec 4, 2024.
How did Reza Zadno's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Reza Zadno has 0.
Where does Reza Zadno file Form 4?
Reza Zadno has filed Form 4 at PRCT (PROCEPT BioRobotics Corp) as President, CEO; MOBI (Mobia Medical, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.